NEW YORK, NY / ACCESSWIRE / January 17, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
OLPX Shareholders Click Here: https://www.zlk.com/pslra-1/olaplex-holdings-lawsuit-submission-form?prid=35707&wire=1
GNRC Shareholders Click Here: https://www.zlk.com/pslra-1/generac-class-action-loss-submission-form?prid=35707&wire=1
TWST Shareholders Click Here: https://www.zlk.com/pslra-1/twist-bioscience-loss-submission-form?prid=35707&wire=1
* ADDITIONAL INFORMATION BELOW *
Olaplex Holdings, Inc. (NASDAQ:OLPX)
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Olaplex common stock pursuant and/or traceable to the Company's initial public offering conducted on or around September 30, 2021.
Lead Plaintiff Deadline : January 17, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/olaplex-holdings-lawsuit-submission-form?prid=35707&wire=1
According to the filed complaint, (i) macroeconomic pressures and competition in the haircare market were more robust than the Company had represented to investors; (ii) accordingly, the Company was unlikely to maintain its sales and revenue momentum; and (iii) as a result, it was unlikely that the Company would be able to achieve the financial and operational growth projected in the offering documents; and (iv) as a result, the offering documents were materially false and/or misleading and failed to state information required to be stated therein.
Generac Holdings Inc. (NYSE:GNRC)
This lawsuit is on behalf of all investors who purchased or otherwise acquired Generac Holdings Inc. common stock between April 29, 2021, and November 1, 2022, inclusive.
Lead Plaintiff Deadline : January 30, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/generac-class-action-loss-submission-form?prid=35707&wire=1
According to the filed complaint, (1) despite defendant's claims that "safety is paramount", Generac's SnapRS units, which are components for rapidly shutting down solar devices in certain dangerous situations, were defective; (2) Generac did not timely record warranty liabilities resulting from the defective SnapRS units; and, (3) despite assurances to the contrary, the Company's sales to channel partners were highly concentrated in a single partner.
Twist Bioscience Corporation (NASDAQ:TWST)
This lawsuit is on behalf of a class of all persons and entities who purchased or otherwise acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive.
Lead Plaintiff Deadline : February 10, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/twist-bioscience-loss-submission-form?prid=35707&wire=1
According to the filed complaint, 1) as alleged in the November 15, 2022 report by Scorpion Capital, defendants overstated the commercial viability of Twist's synthetic DNA manufacturing technology; and 2) at the same time, defendants were engaging in accounting fraud and using unsustainable pricing to inflate the Company's true financial condition and prospects.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP